Literature DB >> 8478040

Effects of weight reduction on cellular cation metabolism and vascular resistance.

D B Jacobs1, J R Sowers, A Hmeidan, T Niyogi, L Simpson, P R Standley.   

Abstract

The early stages of weight loss are associated with a reduction in blood pressure, and the mechanisms mediating this reduction remain unclear. Platelet free calcium levels, [Ca2+]i, have been reported to be elevated in essential hypertension and to decrease with pharmacological treatment of the hypertension. In the current study, 18 obese subjects had measurements of blood pressure, forearm blood flow, forearm vascular resistance, and both basal platelet [Ca2+]i and [Ca2+]i responses to vasopressin during 12 weeks on a very low calorie (3,360 kJ, or 800 kcal) diet. Weight reduction was associated with reduction in mean arterial blood pressure at 3-4 weeks. There were associated reductions in forearm vascular resistance and platelet [Ca2+]i as well as increases in forearm blood flow at 3-4 weeks of the diet. Increased forearm blood flow was correlated with weight loss. Vasopressin-induced platelet [Ca2+]i responses increased, which correlated with the reduction in mean arterial pressure at 7-8 weeks of weight loss. Assuming that platelet [Ca2+]i metabolism reflects vascular smooth muscle cell [Ca2+]i metabolism, the data suggest that blood pressure reduction after weight loss may be related to reduced vascular smooth muscle cell [Ca2+]i. The reason for the increased vasopressin-induced [Ca2+]i after weight reduction is unclear.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8478040     DOI: 10.1161/01.hyp.21.3.308

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  6 in total

Review 1.  The medical risks of obesity.

Authors:  F Xavier Pi-Sunyer
Journal:  Obes Surg       Date:  2002-04       Impact factor: 4.129

Review 2.  Obesity, hypertension, and vascular disease.

Authors:  K M Sowers; J R Sowers
Journal:  Curr Hypertens Rep       Date:  1999 Apr-May       Impact factor: 5.369

Review 3.  Body fat and sympathetic nerve activity.

Authors:  U Scherrer; R Owlya; M Lepori
Journal:  Cardiovasc Drugs Ther       Date:  1996-06       Impact factor: 3.727

Review 4.  The role of obesity in kidney disease: recent findings and potential mechanisms.

Authors:  Rigas G Kalaitzidis; Kostas C Siamopoulos
Journal:  Int Urol Nephrol       Date:  2011-05-05       Impact factor: 2.370

Review 5.  The pathogenesis of hypertension in obese subjects.

Authors:  P Weidmann; M de Courten; L Boehlen; S Shaw
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 6.  Potassium, magnesium, and calcium: their role in both the cause and treatment of hypertension.

Authors:  Mark C Houston; Karen J Harper
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-07       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.